In vitro expression of N-acetyl aspartate by oligodendrocytes: Implications for proton magnetic resonance spectroscopy signal in vivo

Journal of Neurochemistry

Volumn 74, Issue 1, 2000, Pages 254-262

  Bhakoo, Kishore K ^a   Pearce, Daniel ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Brain development; Cell metabolism; Myelination; N Acetyl aspartate; Nuclear magnetic resonance; Oligodendrocyte

Indexed keywords

N ACETYLASPARTIC ACID;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL MATURATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEM CELL;

ANIMALS; ASPARTIC ACID; CELL AGING; CELL SURVIVAL; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CILIARY NEUROTROPHIC FACTOR; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE SPECTROSCOPY; OLIGODENDROGLIA; PROTONS; RATS; STEM CELLS;

ANIMALIA;

EID: 0033961818     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0740254.x     Document Type: Article

References (67)

1. Ahlgren S. C., Wallace H., Bishop J., Neophytou C., and Raff M. C. (1997) Effects of thyroid hormone on embryonic oligodendrocyte precursor cell development in vivo and in vitro. Mol. Cell. Neurosci. 9, 420-432.
2. Almazan G., Honegger P., and Matthieu J. M. (1985) Triiodothyronine stimulation of oligodendroglial differentiation and myelination. A developmental study. Dev. Neurosci. 1, 45-51.
3. 1H NMR spectroscopy in Canavan's disease: a report of two cases. Magn. Res. Med. 19, 439-445.
4. Barres B. A., Hart I. K., Coles H. S., Burne J. F., Voyvodic J. T., Richardson W. D., and Raff M. C. (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70, 31-46.
5. Barres B. A., Schmid R., Sendtner M., and Raff M. C. (1993) Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118, 283-295.
6. Barres B. A., Burne J. F., Holtmann B., Thoenen H., Sendtner M., and Raff M. C. (1996) Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol. Cell. Neurosci. 8, 146-156.
7. Bartalini G., Margollicci M., Balkestri P., Farnetani M. A., Cioni M., and Fois A. (1992) Biochemical diagnosis of Canavan disease. Childs Nerv. Syst. 8, 468-470.
8. Bartlett P. F., Noble M. D., Pruss R. M., Raff M. C., Rattray S., and Williams C. A. (1980) Rat neural antigen-2 (RAN-2): a cell surface antigen on astrocytes, ependymal cells, Muller cells and lepto-meninges defined by a monoclonal antibody. Brain Res. 204, 339-351.
9. Baslow M. H. and Resnik T. R. (1997) Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms. J. Mol. Neurosci. 9, 109-125.
10. 1H NMR study of cerebral development in the rat. NMR Biomed. 2, 225-229.
11. 1H MRS studies in vivo. Neuroreport 7, 1397-1400.
12. Bayer S. A. (1990) Development of the lateral and medial limbic cortices in the rat in relation to cortical phylogeny. Exp. Neurol. 107, 118-131.
13. Bhakoo K. K., Williams I. T., Williams S. R., Gadian D. G., and Noble M. D. (1996) Proton nuclear magnetic resonance spectroscopy of primary cells derived from nervous tissue. J. Neurochem. 66, 1254-1263.
14. 1H-NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev. 13, 23-31.
15. Bogler O., Wren D., Barnett S. C., Land H., and Noble M. (1990) Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc. Natl. Acad. Sci. USA 87, 6368-6372.
16. Bottenstein J. H. and Sato G. H. (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76, 514-517.
17. Cameron H. A. and McKay R. (1998) Stem cells and neurogenesis in the adult brain. Curr. Opin. Neurobiol. 8, 677-680.
18. D'Adamo A. F. J. and Yatsu F. M. (1966) Acelate metabolism in the nervous system. N-Acetyl-L-aspartic acid and the biosynthesis of brain lipids. J. Neurochem. 13, 961-965.
19. D'Adamo A. F. J., Gidez L. I., and Yatsu F. M. J. (1968) Acetyl transport mechanisms. Involvement of N-acetyl aspartic acid in de novo fatty acid biosynthesis in the developing rat brain. Exp. Brain Res. 5, 267-273.
20. Das G. D. and Altman J. (1970) Postnatal neurogenesis in the caudate nucleus and nucleus accumbens septi in the rat. Brain Res. 21, 122-127.
21. Davie C. A., Hawkins C. P., Barker G. J., Brennan A., Tofts P. S., Miller D. H., and McDonald W. I. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117, 49-58.
22. De Stefano N., Matthews P. M., and Arnold D. L. (1995) Reversible decreases in N-acetylaspartate after acute brain injury. Magn. Res. Med. 34, 721-727.
23. De Stefano N., Matthews P. M., Narayanan S., Francis G. S., Antel J. P., and Arnold D. L. (1997) Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology 49, 1138-1141.
24. Eisenbarth G. S., Walsh F. S., and Nirenberg M. (1979) Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. USA 76, 4913-4917.
25. Florian C. L., Preece N. E., Bhakoo K. K., Williams S. R., and Noble M. D. (1995) Cell type-specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy. Cancer Res. 55, 420-427.
26. 1H NMR spectroscopy and high performance liquid chromatography. Neurochem. Res. 21, 1065-1074.
27. Fu L., Matthews P. M., De Stefano N., Worsley K. J., Narayanan S., Francis G. S., Antel J. P., Wolfson C., and Arnold D. L. (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121, 103-113.
28. Gao F. B., Apperly J., and Raff M. (1998) Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells. Dev. Biol. 197, 54-66.
29. Grodd W., Krageloh Mann I., Petersen D., Trefz F. K., and Harzer K. (1990) In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy [Letter]. Lancet 336, 437-438.
30. Harris R. A. and Loh H. H. (1979) Brain sulfatide and non-lipid sulfate metabolism in hypothyroid rats. Res. Commun. Chem. Pathol. Pharmacol. 24, 169-179.
31. 31P NMR spectroscopy of the developing rat brain.] Hokkaido Igaku Zasshi 67, 272-280.
32. Ibarrola N., Mayer Proschel M., Rodriguez Pena A., and Noble M. (1996) Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. Dev. Biol. 180, 1-21.
33. Jagannathan N. R., Tandon N., Raghunathan P., and Kochupillai N. (1998) Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study. Brain Res. Dev. Brain Res. 109, 179-186.
34. Johnson G. D., Davidson R. S., McNamee K. C., Russell G., Goodwin D., and Holborow E. J. (1982) Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. J. Immunol. Methods 55, 231-242.
35. Kato T., Nishina M., Matsushita K., Hori E., Mito T., and Takashima S. (1997) Neuronal maturation and N-acetyl-L-aspartic acid development in human fetal and child brains. Brain Dev. 19, 131-133.
36. Koller K. J., Zaczek R., and Coyle J. T. (1984) N-Acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J. Neurochem. 43, 1136-1142.
37. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
38. Lucchinetti C. F., Brueck W., Rodriguez, M., and Lassmann H. (1998) Multiple sclerosis: lessons from neuropathology. Semin. Neurol. 18, 337-349.
39. Malone M. J., Rosman N. P., Szoke M., and Davis D. (1975) Myelination of brain in experimental hypothyroidism. An electronmicroscopic and biochemical study of purified myelin isolates. J. Neurol. Sci. 26, 1-11.
40. Matthews P. M., Pioro E., Narayanan S., De Stefano N., Fu L., Francis G., Antel J., Wolfson C., and Arnold D. L. (1996) Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 119, 715-722.
41. Matthieu J. M., Reier P. J., and Sawchak J. A. (1975) Proteins of rat brain myelin in neonatal hypothyroidism. Brain Res. 84, 443-451.
42. Mayer M., Bhakoo K., and Noble M. (1994) Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120, 143-153.
43. McMorris F. A. and McKinnon R. D. (1996) Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease. Brain Pathol. 6, 313-329.
44. Moffett J. R., Namboodiri M. A., Cangro C. B., and Neale J. H. (1991) Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 2, 131-134.
45. Nadler J. V. and Cooper J. R. (1972) N-Acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues. J. Neurochem. 19, 313-319.
46. Narayana P. A., Doyle T. J., Lai D., and Wolinsky J. S. (1998) Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann. Neurol. 43, 56-71.
47. Noguchi T., Sugisaki T., Satoh I., and Kudo M. (1985) Partial restoration of cerebral myelination of the congenitally hypothyroid mouse by parenteral or breast milk administration of thyroxine. J. Neurochem. 45, 1419-1426.
48. Pasquini J. M., Faryna-de-Raveglia I. A., Capitman N., and Soto E. F. (1981) Neonatal hypothyroidism and early undernutrition in the rat: defective maturation of structural membrane components in the central nervous system. Neurochem. Res. 6, 979-991.
49. Patel T. B. and Clark J. B. (1979) Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem. J. 184, 539-546.
50. Porterfield S. P. and Hendrich C. E. (1993) The role of thyroid hormones in prenatal and neonatal neurological development - current perspectives. Endocr. Rev. 14, 94-106.
51. Raff M. C., Mirsky R., Fields K. L., Lisak R. P., Dorfman S. H., Silberberg D. H., Gregson N. A., Leibowitz S., and Kennedy M. C. (1978) Galactocerebroside is a specific cell-surface anti-genic marker for oligodendrocytes in culture. Nature 274, 813-816.
52. Raine C. S. (1997) The Norton lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J. Neuroimmunol. 77, 135-152.
53. Rakre P. (1985) Limits of neurogenesis in primates. Science 227, 1054-1055.
54. Ranscht B., Clapshaw P. A., Price J., Noble M., and Seifert W. (1982) Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc. Natl. Acad Sci. USA 79, 2709-2713.
55. Richards T. L. (1991) Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. Am. J. Roentgenol. 157, 1073-1078.
56. Shaag A., Anikster Y., Christensen E., Glustein J. Z., Fois A., Michelakakis H., Nigro F., Pronicka E., Ribes A., Zabot M. T., and Elpeleg O. N. (1995) The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients. Am. J. Hum. Genet. 57, 572-580.
57. Shanker G., Amur S. G., and Pieringer R. A. (1985) Investigations on myelinogenesis in vitro: a study of the critical period at which thyroid hormone exerts its maximum regulatory effect on the developmental expression of two myelin associated markers in cultured brain cells from embryonic mice. Neurochem. Res. 10, 617-625.
58. Simmons M. L., Frondoza C. G., and Coyle J. T. (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45, 37-45.
59. Stockli K. A., Lillien L. E., Naher Noe M., Breitfeld G., Hughes R. A., Raff M. C., Thoenen H., and Sendtner M. (1991) Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain. J. Cell Biol. 115, 447-459.
60. Sugie H., Tsurui S., Ishikawa A., Matsuda F., Sugie Y., Igarashi Y., and Fujise Y. (1990) [Effects of neonatal hypothyroidism on brain development: analysis of brain metabolites using high resolution phosphorus and proton magnetic resonance (NMR) spectroscopy.] No To Hattatsu 22, 166-172.
61. Tallan H. H. (1957) Studies on the distribution of N-acetyl-L-aspartic acid in brain. J. Biol. Chem. 224, 41-45.
62. Tallan H. H., Moore S., and Stein W. H. (1956) N-Acetyl-L-aspartic acid in brain. J. Biol. Chem. 219, 257-26A
63. Toft P. B. (1994) Metabolite concentrations in the developing brain estimated with proton MR spectroscopy. J. Magn. Res. Imag. 4, 674-680.
64. Urenjak J., Williams S. R., Gadian D. G., and Noble M. (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59, 55-61.
65. Urenjak J., Williams S. R., Gadian D. G., and Noble M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981-989.
66. Valcana T., Einstein E. R., Csejtey J., Dalal K. B., and Timiras P. S. (1975) Influence of thyroid hormones on myelin proteins in the developing rat brain. J. Neurol. Sci. 25, 19-27.
67. Zhou L., Trapp B. D., and Miller R. H. (1998) Demyelination in the central nervous system mediated by an anti-oligodendrocyte anti-body. J. Neurosci. Res. 54, 158-168.